Year: 2025
Type: article
Abstract: This Viewpoint examines variations in US commercial health plan coverage restrictions for cell and gene therapies.
Source: JAMA
Institution: Tufts Medical Center
Language: English
Subfield: Economics and Econometrics
Domain: Social Sciences
Open Access status: green
OpenAlex ID: W4414594655